Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Trial ID or NCT#
NCT00398177,,,,,,,,
Status
RECRUITING
Purpose
The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.
Official Title
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
- * Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification, any stage, any grade.* Adult or pediatric patients receiving lymph node excision for purposes other than cancer therapy (i.e. tonsillectomy, sleep apnea).* A routine procedure for tissue collection is planned.* Ability to understand and the willingness to sign a written informed consent.
Exclusion Criteria:
- * Patients without NHL or Hodgkin's disease
Investigator(s)
Ronald Levy, MD
Medical oncologist,
Lymphoma specialist
Robert K. and Helen K. Summy Professor in the School of Medicine
Ash A. Alizadeh, MD/PhD
Medical oncologist,
Lymphoma specialist,
Cancer geneticist
Moghadam Family Professor
Michael Khodadoust
Lymphoma specialist,
Cutaneous oncology specialist,
Hematologist,
Hematologist-Oncologist
Assistant Professor of Medicine (Oncology) and of Dermatology
Contact us to find out if this trial is right for you.
Contact
Alyssa M Kanegai
650-736-1596
View on